Current Pharmacogenomics and Personalized Medicine (CPPM)

Current Pharmacogenomics and Personalized Medicine is an international, peer-reviewed scientific journal devoted to the rapidly evolving disciplines of pharmacogenomics and personalized medicine. Established in 2008, the journal publishes a mix of expert reviews, mini-reviews, original research articles, and thematic discussions that showcase the latest advancements in understanding how genetic and molecular differences influence drug response and therapeutic outcomes. Its scope spans basic genomic and post-genomic biotechnologies, diagnostic innovations, ethical and policy considerations, and practical clinical applications that collectively advance global personalized healthcare. The journal emphasizes translational research that connects molecular mechanisms with clinical decision-making, fostering interdisciplinary communication among researchers, clinicians, and industry stakeholders. Key topics include the development and validation of pharmacogenomic biomarkers, tailored therapeutic interventions, genomic approaches to predicting adverse drug reactions, and integration of personalized strategies into disease management for conditions such as cancer, cardiovascular disorders, and neurological disease. In addition to cutting-edge science, Current Pharmacogenomics and Personalized Medicine encourages discussion of sociological and global health aspects that influence the adoption of personalized medicine practices, particularly in developing regions. With a quarterly publication schedule and continuous online availability, the journal serves as a vital resource for scientists and healthcare professionals seeking to stay informed about advances that drive precision medicine from bench to bedside.

Current Pharmacogenomics and Personalized Medicine (CPPM) is :-

• International, Peer-Reviewed, Open Access, Refereed, Pharmacogenomics, Personalized health interventions, Translational pharmacology, Diagnostics and genomic/post-genomic technologies, Applications in oncology, cardiology, neuropharmacology, endocrine disorders, global health contexts, Ethical, social, policy aspects of personalized medicine research, Pharmacology , Online or Print , Quarterly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1875-6921, E-ISSN: 1875-6913, Established: 2008,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE